Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_assertion description "[Taken together, these findings strongly suggest that the interaction of CD44v3-Vav2 with Grb2-p185(HER2) plays an important role in the co-activation of both Rac1 and Ras signaling that is required for HA-mediated human ovarian tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_assertion evidence source_evidence_literature NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_assertion SIO_000772 11606575 NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_assertion wasDerivedFrom befree-20140225 NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_assertion wasGeneratedBy ECO_0000203 NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP516081.RAKgSiCSzCyigLm5NLmJ7cT3a-LXEbAAyGL63J-JZxMEk130_provenance.